Mometasone Furoate and Formoterol Fumarate Inhaler is a fixed-dose combination therapy used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in patients requiring both inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA).
This combination helps in improving pulmonary function, reducing asthma symptoms and minimizing exacerbation risks, especially in moderate to severe cases.
Explore our diverse range of pharmaceutical manufacturing categories, designed to deliver high-quality, reliable, and innovative healthcare solutions across multiple dosage forms.
Corporate Office
Plot No. :46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India.
Manufacturing Unit
Village Kondi, Post Thana, District Solan, Baddi 173205 Himachal Pradesh, India.
